Skip to content

Public FDA record

Z-0689-03: AxSYM Tricyclic Antidpressants Reagent. Distributied under the following label: AxSYM Abbott Laboratories

Recall record Z-0689-03 for Abbott Health Products, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0689-03
Company in FDA record
Abbott Health Products, Inc.
FDA classification date
Mar 29, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Unexpected false positive TCA results

Source facts

Action
A Device Correction letter was mail to all customers on 12 /11/02. The letter explained the reason for the recall and provided specific instructions.
Initiated
2002-12-11
Root cause
Other
Terminated
2004-06-02
Distribution
Distribution was nationwide, VA/DOD accounts. The foreign distribution was as follows: Mexico, Venezuela, Colombia, Chile, Uruguay, Argentina, Brazil, Canada, England, Japan, Singapore, Hong Kong, Taiwan, Thailand, Costa Rica, New Zealand and Panama
Recall number
Z-0689-03
Recall status
Terminated
CDRH record ID
25407
FDA classified
2003-03-29
Recall event number
25220

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗